We have previously shown that the protein Eps15 is constitutively asso
ciated with the plasma membrane adaptor complex, AP-2, suggesting its
possible role in endocytosis. To explore the role of Eps15 and the fun
ction of AP-2/Eps15 association in endocytosis, the Eps15 binding doma
in for AP-2 was precisely delineated, The entire COOH-terminal domain
of Eps15 or a mutant form lacking all the AP-2-binding sites was fused
to the green fluorescent protein (GFP), and these constructs were tra
nsiently transfected in HeLa cells, Overexpression of the fusion prote
in containing the entire COOH-terminal domain of Eps15 strongly inhibi
ted endocytosis of transferrin, whereas the fusion protein in which th
e AP-2-binding sites had been deleted had no effect. These results wer
e confirmed in a cell-free assay that uses perforated A431 cells to fo
llow the first steps of coated vesicle formation at the plasma membran
e, Addition of Eps15-derived glutathione-S-transferase fusion proteins
containing the AP-2-binding site in this assay inhibited not only con
stitutive endocytosis of transferrin but also ligand-induced endocytos
is of epidermal growth factor, This inhibition could be ascribed to a
competition between the fusion protein and endogenous Eps15 for AP-2 b
inding. Altogether, these results show that interaction of Eps15 with
AP-2 is required for efficient receptor-mediated endocytosis and thus
provide the first evidence that Eps15 is involved in the function of p
lasma membrane-coated pits.